IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Maat Pharma Saca

CUSIP: 00BNRR5C1 | 1 institutional holders

Quarters

Q2 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

Propel Bio Management, LLC1,362
0.0% of portfolio›$9.8K
StyleTurnoverLocationFiled
Propel Bio Management, LLC
1,362$9.8K0.0%ValueHighLos Angeles, CA2024-08-12